Literature DB >> 26058448

Synthesis and Antiproliferative Activity of Silybin Conjugates with Salinomycin and Monensin.

Michał Antoszczak1, Greta Klejborowska1, Monika Kruszyk1, Ewa Maj2, Joanna Wietrzyk2, Adam Huczyński1.   

Abstract

Aiming at development of multitarget drugs for the anticancer treatment, new silybin (SIL) conjugates with salinomycin (SAL) and monensin (MON) were synthesized, in mild esterification conditions, and their antiproliferative activity was studied. The conjugates obtained exhibit anticancer activity against HepG2, LoVo and LoVo/DX cancer cell lines. Moreover, MON-SIL conjugate exhibits higher anticancer potential and better selectivity than the corresponding SAL-SIL conjugate.
© 2015 John Wiley & Sons A/S.

Entities:  

Keywords:  anticancer activity; molecular hybrids; natural products; polyether antibiotics; silibinin

Mesh:

Substances:

Year:  2015        PMID: 26058448     DOI: 10.1111/cbdd.12602

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  6 in total

1.  New Hybrids Derived from Podophyllic Aldehyde and Diterpenylhydroquinones with Selectivity toward Osteosarcoma Cells.

Authors:  Ángela P Hernández; Paula Díez; Pablo A García; José M Miguel Del Corral; Martín Pérez-Andrés; David Díez; Arturo San Feliciano; Manuel Fuentes; Ma Ángeles Castro
Journal:  ACS Med Chem Lett       Date:  2018-03-08       Impact factor: 4.345

2.  Synthesis and Anticancer Activity of Dimeric Polyether Ionophores.

Authors:  Michał Sulik; Ewa Maj; Joanna Wietrzyk; Adam Huczyński; Michał Antoszczak
Journal:  Biomolecules       Date:  2020-07-12

3.  Synthesis of Lasalocid-Based Bioconjugates and Evaluation of Their Anticancer Activity.

Authors:  Michał Antoszczak; Dagmara Otto-Ślusarczyk; Marta Kordylas; Marta Struga; Adam Huczyński
Journal:  ACS Omega       Date:  2022-01-07

Review 4.  Salinomycin as a potent anticancer stem cell agent: State of the art and future directions.

Authors:  Dan Qi; Yunyi Liu; Juan Li; Jason H Huang; Xiaoxiao Hu; Erxi Wu
Journal:  Med Res Rev       Date:  2021-11-16       Impact factor: 12.388

5.  Cholesterol-stabilized membrane-active nanopores with anticancer activities.

Authors:  Jie Shen; Yongting Gu; Lingjie Ke; Qiuping Zhang; Yin Cao; Yuchao Lin; Zhen Wu; Caisheng Wu; Yuguang Mu; Yun-Long Wu; Changliang Ren; Huaqiang Zeng
Journal:  Nat Commun       Date:  2022-10-10       Impact factor: 17.694

6.  Liver Protection Mechanism and Absorption Promotion Technology of Silybin Based on Intelligent Medical Analysis.

Authors:  Bingbing Yan; Chuanying Zhang
Journal:  J Healthc Eng       Date:  2021-07-03       Impact factor: 2.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.